Chargement en cours...
M57. Gastrointestinal Disease Impact on Antipsychotic Induced Weight Gain in Schizophrenia: Analysis of Randomized Controlled Trials
Background: Although atypical antipsychotics have been effective at treating psychotic symptoms, secondary effects including weight gain contribute to the development and exacerbation of chronic disease leading to poor outcomes and attenuated lifespan in schizophrenia. The aim of this study was to e...
Enregistré dans:
| Publié dans: | Schizophr Bull |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475815/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx022.054 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|